Pure Global

Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients - Trial NCT06343168

Access comprehensive clinical trial information for NCT06343168 through Pure Global AI's free database. This phase not specified trial is sponsored by UลŸak University and is currently Completed. The study focuses on Frailty. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06343168
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT06343168
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients

Study Focus

Frailty

prevalence of frailty

Observational

other

Sponsor & Location

UลŸak University

Usak, Turkey

Timeline & Enrollment

N/A

Feb 18, 2021

Feb 18, 2022

96 participants

Primary Outcome

Prevalence of frailty

Summary

This study aimed to determine the prevalence of and factors affecting frailty in patients
 with coronary artery bypass graft.
 
 The main question it aims to answer are:
 
 What are the prevalence of and factors affecting frailty in patients with coronary artery
 bypass graft Type of study: descriptive cross-sectional study Participant population:
 coronary artery bypass grafting patients

ICD-10 Classifications

Unattended death
Individuals with autosomal fragile site

Data Source

ClinicalTrials.gov

NCT06343168

Non-Device Trial